Joyson Karakunnel
Chief Tech/Sci/R&D Officer at ITEOS THERAPEUTICS, INC.
Joyson Karakunnel active positions
Companies | Position | Start | End |
---|---|---|---|
ITEOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 | - |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - | - |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Chief Tech/Sci/R&D Officer | 2017-03-31 | - |
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Director/Board Member | 2021-12-31 | - |
Primevax Immuno-Oncology, Inc.
Primevax Immuno-Oncology, Inc. Medical/Nursing ServicesHealth Services Primevax Immuno-Oncology, Inc. focuses on the development of personalized immunotherapy with its PV-001 platform. The firm develops multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens. The company is headquartered in Orange, CA. | Director/Board Member | - | - |
Career history of Joyson Karakunnel
Former positions of Joyson Karakunnel
Companies | Position | Start | End |
---|---|---|---|
INNATE PHARMA | Chief Tech/Sci/R&D Officer | 2020-07-15 | 2023-10-30 |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2019-06-30 | 2020-06-30 |
Uniformed Services University of the Health Sciences | Corporate Officer/Principal | 2010-12-31 | 2017-03-31 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Director/Board Member | 2013-05-31 | 2017-03-31 |
░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Joyson Karakunnel
University of Maryland | Graduate Degree |
University of Miami | Undergraduate Degree |
Annamalai University | Doctorate Degree |
Kelley School of Business | Masters Business Admin |
Statistics
International
United States | 13 |
France | 2 |
India | 2 |
Operational
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 6 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
INNATE PHARMA | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
ITEOS THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Retail Trade |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
Primevax Immuno-Oncology, Inc.
Primevax Immuno-Oncology, Inc. Medical/Nursing ServicesHealth Services Primevax Immuno-Oncology, Inc. focuses on the development of personalized immunotherapy with its PV-001 platform. The firm develops multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens. The company is headquartered in Orange, CA. | Health Services |
- Stock Market
- Insiders
- Joyson Karakunnel
- Experience